{"id":"NCT00313911","sponsor":"Sanofi Pasteur, a Sanofi Company","briefTitle":"Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.","officialTitle":"Large Scale Safety Study of a DTaP-IPV-Hep B-PRP~T Combined Vaccine, in Comparison to Tritanrix-Hep B/Hib™ and OPV Administered at 2, 4, and 6 Months of Age in Latin American Infants","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-07","primaryCompletion":"2008-01","completion":"2008-02","firstPosted":"2006-04-12","resultsPosted":"2012-11-19","lastUpdate":"2014-04-21"},"enrollment":2133,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Diphtheria","Tetanus","Pertussis","Haemophilus Influenzae Type b","Hepatitis B"],"interventions":[{"type":"BIOLOGICAL","name":"DTaP-IPV-HB-PRP~T","otherNames":[]},{"type":"BIOLOGICAL","name":"Tritanrix-HepB/Hib","otherNames":[]}],"arms":[{"label":"Group 1: DTaP-IPV-Hep B-PRP-T","type":"EXPERIMENTAL"},{"label":"Group 2: Tritanrix-Hep B/Hib™+OPV","type":"ACTIVE_COMPARATOR"}],"summary":"To demonstrate that DTaP-IPV-HB-PRP\\~T combined vaccine does not induce a higher incidence rate of high fever than Tritanrix-HepB/Hib™ and Oral Polio Vaccine (OPV) after any of the three vaccinations at 2, 4, and 6 months of age for each subject.\n\nTo evaluate the overall safety in terms of:\n\nAny solicited adverse reactions in the first 7 days after each injection, Any adverse events and reactions in the first 30 days after each injection, Any serious adverse events during the trial.\n\nImmunogenicity:\n\nTo document the immune response to Hepatitis B antigen of the three batches of the investigational DTaP-IPV-HB-PRP\\~T vaccine.","primaryOutcome":{"measure":"Number of Participants With High Fever Observed After Either DTaP-IPV-Hep B-PRP~T or Tritanrix Hep B/Hib™ + Placebo or Tritanrix-Hep B/Hib™ + Placebo Injection.","timeFrame":"Day 0 up to Day 7 post-injection","effectByArm":[{"arm":"DTaP-IPV-Hep B-PRP~T","deltaMin":56,"sd":null},{"arm":"Tritanrix-Hep B/Hib™ + OPV","deltaMin":39,"sd":null}],"pValues":[]},"eligibility":{"minAge":"50 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":15},"locations":{"siteCount":2,"countries":["Mexico","Peru"]},"refs":{"pmids":["22531237"],"seeAlso":["http://www.sanofipasteur.com"]},"adverseEventsSummary":{"seriousAny":{"events":91,"n":1423},"commonTop":["Solicited Irritability post-dose 1","Solicited Injection Site Pain Post-dose 1","Solicited Crying Post-dose 1","Solicited Pyrexia Post-dose 2","Nasopharyngitis"]}}